Applied AI for life-sciences and academic enterprises

Unlock the value of your intangible assets.

Athar helps universities, research institutes and life-sciences companies decide what to do with their IP, value it and plan how to fund it. Our engineers deploy it inside your institution, alongside your team.

Now taking design partners in Saudi Arabia and the GCC.

AtharSaudi university portfolioDemonstration
KSA-001Preclinical

Anti-MERS-CoV spike nanobody

  • Overview
  • Decision
  • Value
  • Evidence
  • Risk
  • Memo
  1. EvidencePartial
  2. RiskPartial
  3. ValueEstimated
  4. ActionRecommended
  5. CapitalRecommended
Next stepRun the experiment: replicated in vivo protection study
Cost
SAR 1.1M
p(success)
65%
Expected RoD
1.2×
Value to the owner todaySAR 1.2MEstimated · low confidence−SAR 90KSAR 5.4M
Risk profile
  • IP / legal
  • Science
  • Translation
  • Clinical
  • Competition
  • Market

Synthetic demonstration data. Valuation policies stay illustrative until approved with each partner.

Built for the institutions that own the science.

Each team starts from the question it has to answer this quarter.

Universities and TTOs

Which patents do we keep paying for?

See every asset's value, risk and next step, and stop spending where the evidence says stop.

Life-sciences companies

Which programme earns the next riyal?

Compare running the next experiment, licensing now and holding, in one unit of value.

Funders and national programmes

Where does funding de-risk the most?

Rank translational grants by Return on De-Risking across a whole portfolio.

Deployed with your team, not handed over.

Athar is an enterprise platform delivered by forward-deployed engineers who work inside your institution.

  1. 01

    Embed

    A small Athar team joins your TTO, investment or research office and learns how decisions are made today.

  2. 02

    Connect

    We bring your patent records, research evidence and budgets into one source-linked portfolio.

  3. 03

    Calibrate

    Your committee reviews and approves the valuation policy and inputs. Nothing is valued on assumptions you have not seen.

  4. 04

    Decide

    Every asset gets a next step, a value with its range and a recommended capital pathway, ready for the committee.

From a patent to a capital decision.

A recorded walkthrough of the Saudi university demonstration portfolio.

0:00 / 0:28
Read the walkthrough

The workspace opens with Ask Athar: chat across the demonstration portfolios using source-linked records, then explore assets, triage and budgets. KSA-001 compares Stop, the decisive experiment and Commit by expected value and Return on De-Risking; the result is a recommendation, not an approved decision. The loop connects Evidence, Risk, Value, Action and Capital, and missing inputs stay missing. Recorded history is kept separate from simulated demonstration events. The translational budget ranks funded actions by RoD in SAR; switching to USD changes display only. All assets and calculations are synthetic; no client data, provider call, approval or spending is involved.

Evidence

Every claim, with its source.

See what was observed, what is assumed and what is still missing. Every number links back to its source.

EvidenceKSA-001

A clear evidence trail.

  • Source-linked recordsLinked
  • Evidence gapsVisible
  • Recorded and simulated historySeparate
Decisions

The next step, against stopping.

Stop, hold, run the decisive experiment or license now: each option is valued in the owner's money and ranked by Return on De-Risking. Athar recommends; your committee decides.

DecisionKSA-001

What each option adds over stopping.

  • Hold and re-offer laterRoD —
  • Decisive experimentRecommended · 1.2×
  • License nowRoD 3.1×
  • StopBaseline

0× is break-even with stopping.

Capital

A recommended pathway, not a deal.

Rank funded actions within a translational budget and see the recommended pathway for each asset, such as a translational grant, licensing or venture co-funding. It is a recommendation: eligibility, timing and terms are not assessed, and no funder or partner has committed.

Capital pathwayKSA-001

The next riyal, considered.

Recommended pathwayTranslational grant

Prioritise the next experiment within your budget.

Models read the evidence. Deterministic engines compute every number.

Language models find and cite the evidence. Every value, probability and ranking comes from a deterministic engine your auditors can follow.

Why Athar

Most of a university's value sits in assets no one has priced.

Patents, data and know-how are decided on in spreadsheets, slide decks and committee memory. The evidence, the value and the financing live in different places.

Athar puts them in one working view and keeps every number traceable. We are building it with our first design partners, starting with life-sciences IP in Saudi Arabia and the GCC.

Discuss your institution’s portfolio

Controls an investment committee can trust.

Confidential research comes in only after a data boundary is agreed with your institution.

Approved access

Only verified, approved accounts sign in. Access is checked on the server before every session.

Organisation-scoped records

Imported records are visible only to members of the organisation that imported them.

Maker and approver

A valuation policy counts only once it is approved; an owner approving their own policy must confirm it explicitly, and every approval is recorded.

Traceable numbers

Every figure links to its inputs, its policy version and the engine that computed it.

Next: hosting in Saudi Arabia for regulated deployments.

Bring Athar into your institution.

Tell us about your portfolio and the decisions ahead. We are taking design partners in Saudi Arabia and the GCC.

  1. 01 Share your business contact details.
  2. 02 A short call about your portfolio and decisions.
  3. 03 We scope a deployment with your team.
أثر

athar (n.) · impact; the trace something leaves behind.

Business contact details only. Please do not include confidential research. Existing partner? Log in.